Bivirkninger under behandlingen med erytropoietin er især observeres hos patienter med kronisk nyresvigt eller underliggende maligniteter.
Undesirable effects during treatment with erythropoietin are observed predominantly in patients with chronic renal failure or underlying malignancies.